The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...

As more cases of bird flu emerge across the country, public health leaders in New York City are watching warily -- and making ...

Moderna is working with the Department of Health and Human Services to develop a vaccine to combat bird flu. Human to human ...

Concerns about bird flu are growing among health officials weeks after the first person in the U.S. died from the virus, and ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

Moderna's stock roared higher on the back of ... The company is currently working on vaccines for RSV and the seasonal flu, as well as some rare diseases. However, right now, it is still seeing ...

Moderna works on mRNA vaccines ... The company is currently working on vaccines for RSV and the seasonal flu, as well as some rare diseases. However, right now, it is still seeing stagnating ...

The trial looked at the efficacy of mRNA-1083 in one group of adults 65 years and older who received Moderna’s jab or Sanofi’s high-dose flu vaccine Fluzone HD, co-administered with Moderna ...

Volunteers in north Wales are among 25,000 people taking part in a global trial to find a vaccine against the symptoms of the ...

In return for the funding, funds managed by Blackstone will be in line to receive milestones and royalties on any flu vaccine products that emerge from the programme. Moderna will see a reduction ...